Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Fowler

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|August 2, 2014
Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?Floor J Backes, Caroline C Billingsley, Douglas D Martin, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Gynecologic Oncology|July 26, 2005
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group studyBenjamin E Greer, Brian N Bundy, Robert F Ozols, et al.
Journal of Minimally Invasive Gynecology|January 10, 2015
Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancerMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Gynecologic Oncology|December 31, 2021
Who will be readmitted? Evaluation of the laparoscopic hysterectomy readmission score in a gynecologic oncology population undergoing robotic-assisted hysterectomyMichelle D S Lightfoot, Ashley S Felix, Erin E Bishop, et al.
Gynecologic Oncology|July 17, 2021
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal CancerFloor J Backes, Lai Wei, Min Chen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic ChemotherapyCaroline C Billingsley, Samuel N Jacobson, Sarah M Crafton, et al.
Journal of Minimally Invasive Gynecology|January 19, 2016
A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial CancerDavid E Cohn, Karina Castellon-Larios, Laura Huffman, et al.
Gynecologic Oncology|May 5, 2012
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centersAmanda Nickles Fader, Leigh G Seamon, Pedro F Escobar, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|August 2, 2014
Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?Floor J Backes, Caroline C Billingsley, Douglas D Martin, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Gynecologic Oncology|July 26, 2005
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group studyBenjamin E Greer, Brian N Bundy, Robert F Ozols, et al.
Journal of Minimally Invasive Gynecology|January 10, 2015
Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancerMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Gynecologic Oncology|December 31, 2021
Who will be readmitted? Evaluation of the laparoscopic hysterectomy readmission score in a gynecologic oncology population undergoing robotic-assisted hysterectomyMichelle D S Lightfoot, Ashley S Felix, Erin E Bishop, et al.
Gynecologic Oncology|July 17, 2021
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal CancerFloor J Backes, Lai Wei, Min Chen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic ChemotherapyCaroline C Billingsley, Samuel N Jacobson, Sarah M Crafton, et al.
Journal of Minimally Invasive Gynecology|January 19, 2016
A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial CancerDavid E Cohn, Karina Castellon-Larios, Laura Huffman, et al.
Gynecologic Oncology|May 5, 2012
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centersAmanda Nickles Fader, Leigh G Seamon, Pedro F Escobar, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Pageof 11